Can gallic acid potentiate the antihyperglycemic effect of acarbose and metformin? Evidence from streptozotocin-induced diabetic rat model.
Olayemi Philemon AroMariam Damilola OgunbadejoOpeyemi Babatunde OgunsuyiSunday Idowu OyeleyePublished in: Archives of physiology and biochemistry (2020)
This study investigated the influence of dietary phenolic acid- Gallic acid (GA) on the antihyperglycemic properties of acarbose (ACA) and metformin (MET). Streptozotocin-induced diabetic rats were treated (p.o) with ACA, MET, GA and their combinations for 14 days. The effects of the treatments on blood glucose and insulin levels, pancreas α-amylase and intestinal α-glucosidase activities, as well as thiobarbituric acid reactive species (TBARS), thiol and reactive oxygen species (ROS) levels, including antioxidant enzyme activities were investigated. A significant increase in blood glucose, insulin, ROS and TBARS levels, and impaired antioxidant status, as well as elevation in the activities of α-amylase and α-glucosidase observed in diabetic rats were ameliorated in the treatment groups. Hpwever, GA had varying effects on the antidiabetic properties of the drugs. Nevertheless, GA showed more potentiating effects on the antidiabetic effect of MET and these effects were better observed at the lower dose of GA.
Keyphrases
- diabetic rats
- oxidative stress
- pet ct
- blood glucose
- glycemic control
- reactive oxygen species
- type diabetes
- dna damage
- cell death
- tyrosine kinase
- molecular docking
- healthcare
- metabolic syndrome
- atomic force microscopy
- adipose tissue
- endothelial cells
- affordable care act
- wound healing
- replacement therapy
- weight loss
- single molecule
- health insurance